These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26738763)

  • 21. Complications of Pneumococcal Bacteremia After Thirteen-valent Conjugate Vaccine Withdrawal.
    Tagarro A; Bote P; Sánchez A; Otheo E; Sanz JC; Sanz-Rosa D;
    Pediatr Infect Dis J; 2016 Dec; 35(12):1281-1287. PubMed ID: 27434828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced.
    Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G
    Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redistribution of Streptococcus pneumoniae Serotypes After Nationwide 13-valent Pneumococcal Conjugate Vaccine Program in Children in Northern Taiwan.
    Cho YC; Chiu NC; Lu CY; Huang DT; Huang FY; Chang LY; Huang LM; Chi H
    Pediatr Infect Dis J; 2017 Dec; 36(12):e334-e340. PubMed ID: 28650416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
    Savulescu C; Krizova P; Lepoutre A; Mereckiene J; Vestrheim DF; Ciruela P; Ordobas M; Guevara M; McDonald E; Morfeldt E; Kozakova J; Varon E; Cotter S; Winje BA; Munoz-Almagro C; Garcia L; Castilla J; Smith A; Henriques-Normark B; Celentano LP; Hanquet G;
    Lancet Respir Med; 2017 Aug; 5(8):648-656. PubMed ID: 28359798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel.
    Porat N; Benisty R; Givon-Lavi N; Trefler R; Dagan R
    Vaccine; 2016 May; 34(25):2806-12. PubMed ID: 27113163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7.
    Regev-Yochay G; Rahav G; Strahilevitz J; Bishara J; Katzir M; Chowers M; Finkelstein R; Chazan B; Zimhony O; Dagan R;
    Vaccine; 2013 May; 31(19):2387-94. PubMed ID: 23518404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteremia in febrile children under 3 years of age in an emergency department of a university hospital.
    Al-Rashed AM
    Saudi Med J; 2008 Feb; 29(2):229-33. PubMed ID: 18246232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines.
    Koutouzis EI; Michos A; Koutouzi FI; Chatzichristou P; Parpounas K; Georgaki A; Theodoridou M; Tsakris A; Syriopoulou VP
    Pediatr Infect Dis J; 2016 Mar; 35(3):292-6. PubMed ID: 26569193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.